Bristol-Myers Squibb (BMY) Short Interest Ratio & Short Volume $57.97 +0.09 (+0.16%) (As of 10:31 AM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Bristol-Myers Squibb Short Interest DataBristol-Myers Squibb (BMY) has a short interest of 23.42 million shares, representing 1.15% of the float (the number of shares available for trading by the public). This marks a 4.09% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.1, indicating that it would take 2.1 days of the average trading volume of 14.37 million shares to cover all short positions.Current Short Interest23,420,000 sharesPrevious Short Interest22,500,000 sharesChange Vs. Previous Month+4.09%Dollar Volume Sold Short$1.31 billionShort Interest Ratio2.1 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares2,028,180,000 sharesFloat Size2,030,000,000 sharesShort Percent of Float1.15%Today's Trading Volume985,151 sharesAverage Trading Volume14,366,768 sharesToday's Volume Vs. Average7% Short Selling Bristol-Myers Squibb? Sign up to receive the latest short interest report for Bristol-Myers Squibb and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBMY Short Interest Over TimeBMY Days to Cover Over TimeBMY Percentage of Float Shorted Over Time Ad Angel PublishingTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.Click here to get the details. Bristol-Myers Squibb Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202423,420,000 shares $1.31 billion +4.1%1.2%2.1 $55.74 10/15/202422,500,000 shares $1.19 billion +12.3%1.1%1.9 $52.76 9/30/202420,030,000 shares $1.04 billion -8.1%1.0%1.5 $51.74 9/15/202421,790,000 shares $1.07 billion -2.1%1.1%1.6 $49.13 8/31/202422,260,000 shares $1.11 billion -20.5%1.1%1.5 $49.95 8/15/202428,010,000 shares $1.38 billion +6.0%1.4%1.8 $49.12 Get the Latest News and Ratings for BMY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bristol-Myers Squibb and its competitors with MarketBeat's FREE daily newsletter. 7/31/202426,420,000 shares $1.26 billion -17.6%1.3%1.6 $47.56 7/15/202432,060,000 shares $1.29 billion +1.4%1.6%2 $40.15 6/30/202431,620,000 shares $1.31 billion +4.4%1.6%2.1 $41.53 6/15/202430,290,000 shares $1.25 billion +5.4%1.5%2.1 $41.20 5/31/202428,730,000 shares $1.18 billion +1.6%1.4%1.8 $41.13 5/15/202428,270,000 shares $1.26 billion +0.9%1.4%1.8 $44.55 4/30/202428,020,000 shares $1.23 billion -18.5%1.4%1.8 $43.96 4/15/202434,360,000 shares $1.67 billion -2.2%1.7%2.2 $48.51 3/31/202435,120,000 shares $1.90 billion -5.7%1.7%2.2 $54.23 3/15/202437,250,000 shares $1.96 billion +14.1%1.8%2.2 $52.49 2/29/202432,650,000 shares $1.66 billion +3.7%1.6%2.1 $50.73 2/15/202431,490,000 shares $1.56 billion +1.3%1.6%2.1 $49.45 1/31/202431,090,000 shares $1.52 billion +6.5%1.5%2 $48.87 1/15/202429,190,000 shares $1.47 billion +30.8%1.4%1.9 $50.31 12/31/202322,310,000 shares $1.14 billion -7.4%1.1%1.5 $51.31 12/15/202324,100,000 shares $1.23 billion -11.3%1.2%1.7 $50.84 11/30/202327,170,000 shares $1.34 billion +1.4%1.3%2 $49.38 11/15/202326,800,000 shares $1.38 billion +14.5%1.3%2.1 $51.60 10/31/202323,400,000 shares $1.21 billion -12.5%1.2%1.9 $51.53 10/15/202326,750,000 shares $1.51 billion -15.3%1.3%2.4 $56.47 9/30/202331,590,000 shares $1.83 billion -14.6%1.5%2.9 $58.04 9/15/202336,980,000 shares $2.18 billion -15.5%1.8%3.5 $59.00 8/31/202343,760,000 shares $2.70 billion -18.2%2.1%4.4 $61.65 8/15/202353,510,000 shares $3.30 billion +221.6%2.6%5.6 $61.75 7/31/202316,640,000 shares $1.04 billion -8.6%0.8%1.9 $62.20 7/15/202318,210,000 shares $1.13 billion +1.2%0.9%2.2 $61.94 6/30/202318,000,000 shares $1.15 billion -1.9%0.9%2.2 $63.94 6/15/202318,340,000 shares $1.19 billion -2.7%0.9%2.3 $64.68 5/31/202318,840,000 shares $1.21 billion -12.3%0.9%2.3 $64.44 5/15/202321,490,000 shares $1.46 billion +13.6%1.0%2.7 $68.17 4/30/202318,920,000 shares $1.26 billion +5.8%0.9%2.4 $66.77 4/15/202317,880,000 shares $1.26 billion +3.5%0.9%2.3 $70.45 3/31/202317,270,000 shares $1.20 billion -17.0%0.8%2.1 $69.31 3/15/202320,810,000 shares $1.40 billion +22.3%1.0%2.5 $67.48Trump said you could learn something from this man (Ad)Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement. Here’s everything you need to know. 2/28/202317,020,000 shares $1.17 billion -4.0%0.8%2.1 $68.96 2/15/202317,720,000 shares $1.27 billion -14.5%0.9%2.1 $71.47 1/31/202320,720,000 shares $1.51 billion -1.2%1.0%2.3 $72.65 1/15/202320,960,000 shares $1.52 billion +14.9%1.0%2.3 $72.51 12/30/202218,250,000 shares $1.31 billion -26.7%0.9%2 $71.95 12/15/202224,880,000 shares $1.87 billion -1.4%1.2%2.6 $75.00 11/30/202225,220,000 shares $2.02 billion +3.5%1.2%2.6 $80.28 11/15/202224,360,000 shares $1.86 billion -1.7%1.2%2.5 $76.28 10/31/202224,770,000 shares $1.92 billion +7.3%1.2%2.6 $77.47 10/15/202223,080,000 shares $1.63 billion -4.6%1.1%2.5 $70.62 9/30/202224,180,000 shares $1.72 billion +4.7%1.1%2.5 $71.09 9/15/202223,090,000 shares $1.66 billion +1.7%1.1%2.4 $71.78 8/31/202222,710,000 shares $1.53 billion -4.7%1.1%2.2 $67.41 8/15/202223,840,000 shares $1.78 billion -14.3%1.1%2.2 $74.53 7/31/202227,830,000 shares $2.05 billion +1.8%1.3%2.3 $73.78 7/15/202227,330,000 shares $2.07 billion -29.9%1.3%2 $75.65 6/30/202238,980,000 shares $3.00 billion +13.1%1.8%2.7 $77.00 6/15/202234,460,000 shares $2.52 billion +4.3%1.6%2.3 $73.02 5/31/202233,040,000 shares $2.49 billion +2.7%1.6%2.2 $75.45 5/15/202232,180,000 shares $2.44 billion -9.0%1.5%2.1 $75.80 4/30/202235,370,000 shares $2.66 billion -16.3%1.7%2.2 $75.27 4/15/202242,240,000 shares $3.27 billion -10.8%2.0%2.8 $77.51 3/31/202247,340,000 shares $3.46 billion -11.9%2.2%3.1 $73.03 3/15/202253,730,000 shares $3.75 billion -15.0%2.4%3.8 $69.75 2/28/202263,200,000 shares $4.34 billion -10.8%2.9%4.5 $68.67 2/15/202270,880,000 shares $4.80 billion +171.4%3.2%4.9 $67.77 1/31/202226,120,000 shares $1.69 billion +10.2%1.2%1.9 $64.89 1/15/202223,710,000 shares $1.54 billion +16.6%1.1%1.8 $64.93 12/31/202120,340,000 shares $1.27 billion -7.3%0.9%1.6 $62.35 12/15/202121,930,000 shares $1.33 billion -5.7%1.0%1.7 $60.61 11/30/202123,260,000 shares $1.25 billion +14.8%1.1%1.9 $53.63 11/15/202120,260,000 shares $1.21 billion -9.6%0.9%1.8 $59.62 10/29/202122,400,000 shares $1.31 billion +7.5%1.0%2.2 $58.40 10/15/202120,830,000 shares $1.22 billion +4.6%0.9%2.2 $58.36 9/30/202119,910,000 shares $1.18 billion -5.2%0.9%2.2 $59.17 9/15/202120,990,000 shares $1.30 billion +3.3%1.0%2.4 $62.00 8/31/202120,320,000 shares $1.36 billion +5.1%0.9%2.4 $66.86 8/13/202119,340,000 shares $1.31 billion -11.7%0.9%2.2 $67.51 7/30/202121,910,000 shares $1.49 billion +13.1%1.0%2.4 $67.87 7/15/202119,380,000 shares $1.31 billion +19.8%N/A2 $67.43 6/30/202116,180,000 shares $1.08 billion -22.2%N/A1.6 $66.82 6/15/202120,790,000 shares $1.40 billion +24.0%N/A2 $67.42 5/28/202116,770,000 shares $1.10 billion +4.9%N/A1.6 $65.72 5/14/202115,990,000 shares $1.04 billion -23.8%N/A1.4 $65.04 4/30/202120,970,000 shares $1.32 billion +10.5%N/A1.7 $62.89 4/15/202118,980,000 shares $1.21 billion +12.6%N/A1.5 $63.81 3/31/202116,860,000 shares $1.07 billion -33.0%N/A1.3 $63.31 3/15/202125,160,000 shares $1.53 billion -10.8%N/A2 $60.64 2/26/202128,190,000 shares $1.75 billion +35.6%N/A2.3 $62.10 2/12/202120,790,000 shares $1.25 billion +6.8%N/A1.8 $59.99Trump said you could learn something from this man (Ad)Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement. Here’s everything you need to know. 1/29/202119,470,000 shares $1.21 billion -1.3%N/A1.7 $62.29 1/15/202119,730,000 shares $1.30 billion +31.4%N/A1.8 $66.02 12/31/202015,020,000 shares $930.04 million -2.5%N/A1.4 $61.92 12/15/202015,410,000 shares $924.14 million +0.7%N/A1.5 $59.97 11/30/202015,300,000 shares $964.67 million -5.2%N/A1.5 $63.05 11/15/202016,140,000 shares $1.03 billion +2.7%N/A1.5 $63.62 10/30/202015,710,000 shares $909.92 million +14.3%N/A1.5 $57.92 10/15/202013,750,000 shares $1.49 billion +18.3%N/A1.4 $108.24 9/30/202011,620,000 shares $1.26 billion -19.1%N/A1.2 $108.24 9/15/202014,360,000 shares $1.55 billion -3.4%N/A1.4 $108.24 8/31/202014,860,000 shares $1.61 billion +2.8%N/A1.3 $108.24 8/14/202014,450,000 shares $1.56 billion -30.2%N/A1.1 $108.24 7/31/202020,700,000 shares $2.24 billion -9.6%N/A1.5 $108.24 7/15/202022,890,000 shares $2.48 billion +5.8%N/A1.6 $108.24 6/30/202021,640,000 shares $2.34 billion -29.3%1.3%1.4 $108.24 6/15/202030,590,000 shares $1.69 billion -18.0%N/A1.8 $55.10 5/29/202037,320,000 shares $4.04 billion +8.4%N/A2.2 $108.24 5/15/202034,430,000 shares $3.73 billion +8.0%N/A2 $108.24 4/30/202031,870,000 shares $3.45 billion -3.6%N/A2 $108.24 4/15/202033,050,000 shares $3.58 billion +20.4%N/A2 $108.24 3/31/202027,440,000 shares $1.71 billion -39.3%N/A1.7 $62.25 3/13/202045,174,800 shares $2.66 billion -7.8%N/A3.1 $58.91 2/28/202048,970,000 shares $2.27 billion -20.1%N/A3.4 $46.40 2/14/202061,290,000 shares $3.55 billion -3.8%N/A4.1 $57.93 1/31/202063,720,000 shares $3.95 billion +15.9%N/A3.5 $62.04 1/15/202055,000,000 shares $3.68 billion -19.1%N/A3 $66.99 12/31/201967,980,000 shares $4.36 billion -8.5%N/A3.8 $64.16 12/13/201974,320,000 shares $4.75 billion -23.6%4.6%4.2 $63.96 BMY Short Interest - Frequently Asked Questions What is Bristol-Myers Squibb's current short interest? Short interest is the volume of Bristol-Myers Squibb shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 23,420,000 shares of BMY short. 1.15% of Bristol-Myers Squibb's shares are currently sold short. Learn More on Bristol-Myers Squibb's current short interest. What is a good short interest ratio for Bristol-Myers Squibb? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BMY shares currently have a short interest ratio of 2.0. Learn More on Bristol-Myers Squibb's short interest ratio. Which institutional investors are shorting Bristol-Myers Squibb? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Bristol-Myers Squibb: Barclays PLC, Jane Street Group LLC, Wolverine Trading LLC, Readystate Asset Management LP, Point72 DIFC Ltd, Parallax Volatility Advisers L.P., Paloma Partners Management Co, Verition Fund Management LLC, Capstone Investment Advisors LLC, Walleye Trading LLC, Walleye Capital LLC, BNP Paribas Financial Markets, LPL Financial LLC, LMR Partners LLP, Wolverine Asset Management LLC, SpiderRock Advisors LLC, Caas Capital Management LP, IMC Chicago LLC, Concourse Financial Group Securities Inc., and SG Americas Securities LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Bristol-Myers Squibb? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.15% of Bristol-Myers Squibb's floating shares are currently sold short. Is Bristol-Myers Squibb's short interest increasing or decreasing? Bristol-Myers Squibb saw a increase in short interest in October. As of October 31st, there was short interest totaling 23,420,000 shares, an increase of 4.1% from the previous total of 22,500,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Bristol-Myers Squibb's float size? Bristol-Myers Squibb currently has issued a total of 2,028,177,000 shares. Some of Bristol-Myers Squibb's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bristol-Myers Squibb currently has a public float of 2,030,000,000 shares. How does Bristol-Myers Squibb's short interest compare to its competitors? 1.15% of Bristol-Myers Squibb's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Bristol-Myers Squibb: Johnson & Johnson (0.75%), AbbVie Inc. (1.03%), Merck & Co., Inc. (1.04%), Pfizer Inc. (1.09%), Zoetis Inc. (0.96%), Royalty Pharma plc (3.84%), Jazz Pharmaceuticals plc (6.15%), Corcept Therapeutics Incorporated (20.84%), Perrigo Company plc (3.64%), Supernus Pharmaceuticals, Inc. (12.86%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Bristol-Myers Squibb stock? Short selling BMY is an investing strategy that aims to generate trading profit from Bristol-Myers Squibb as its price is falling. BMY shares are trading down $0.35 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Bristol-Myers Squibb? A short squeeze for Bristol-Myers Squibb occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BMY, which in turn drives the price of the stock up even further. How often is Bristol-Myers Squibb's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BMY, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies JNJ Short Interest ABBV Short Interest MRK Short Interest PFE Short Interest ZTS Short Interest RPRX Short Interest JAZZ Short Interest CORT Short Interest PRGO Short Interest SUPN Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:BMY) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bristol-Myers Squibb Please log in to your account or sign up in order to add this asset to your watchlist. Share Bristol-Myers Squibb With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
